Basics |
Company: |
MEI Pharma, Inc. |
IPO Date: |
January 1, 2004 |
Sector: |
Healthcare |
Industry: |
Biotech |
Market Cap: |
$17.32M |
Activated in VL: |
True |
Average Daily Range |
Avg Daily Range: |
$0.10 | 3.08%
|
Avg Daily Range (30 D): |
$0.05 | 1.84%
|
Avg Daily Range (90 D): |
$0.05 | 1.73%
|
Institutional Daily Volume |
Avg Daily Volume: |
.03M |
Avg Daily Volume (30 D): |
.01M |
Avg Daily Volume (90 D): |
.03M |
Trade Size |
Avg Trade Size (Sh.): |
18 |
Avg Trade Size (Sh.) (30 D): |
178 |
Avg Trade Size (Sh.) (90 D): |
197 |
Institutional Trades |
Total Inst.Trades: |
127 |
Avg Inst. Trade: |
$1.57M |
Avg Inst. Trade (30 D): |
$.74M |
Avg Inst. Trade (90 D): |
$.74M |
Avg Inst. Trade Volume: |
.02M |
Avg Inst. Trades (Per Day): |
1 |
Market Closing Trades |
Avg Closing Trade: |
$2.41M |
Avg Closing Trade (30 D): |
$M |
Avg Closing Trade (90 D): |
$M |
Avg Closing Volume: |
47.72K |
|
|
|
|
Financials |
|
TTM |
Q2 2025 |
Q1 2025 |
Basic EPS
|
$-5.73
|
$-.4
|
$-1.2
|
Diluted EPS
|
$-5.73
|
$-.4
|
$-1.2
|
Revenue
|
$ M
|
$ M
|
$ M
|
Gross Profit
|
$
|
$
|
$
|
Net Income / Loss
|
$ -38.22M
|
$ -2.68M
|
$ -8.01M
|
Operating Income / Loss
|
$ -40.61M
|
$ -3.45M
|
$ -8.35M
|
Cost of Revenue
|
$
|
$
|
$
|
Net Cash Flow
|
$ -1.47M
|
$ M
|
$ M
|
PE Ratio
|
|
|
|
Splits |
Apr 17, 2023:
20:1
|
Dec 19, 2012:
6:1
|
Mar 31, 2010:
10:1
|
|